CLASS II ONGOING Device recall · Reported 26 Jul 2023 · FDA Enforcement Report

OBView Versions 4.8.2 SP6 - 4.8.3, Ultrasound reporting recalled

Digisonics is recalling OBView Versions 4.8.2 SP6 - 4.8.3, Ultrasound reporting, distributed in 19 states. The recall was initiated on 26 Jun 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI?DI 00857050006014, Versions 4.8.2 SP6 - 4.8.3
Quantity recalled32 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2214-2023
FDA event ID
92619
Recalling firm
Digisonics, Raleigh, NC
Classification
Class II
Status
Ongoing
Recall initiated
26 Jun 2023
FDA classified
20 Jul 2023
Reported
26 Jul 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

26 Jun 2023Recall initiated by company
20 Jul 2023Classified by FDA+24 days
26 Jul 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Software issue

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Digisonics OBView Versions 4.8.2 SP6 - 4.8.3, Ultrasound reporting software

Where it was distributed

US Distribution: AK, NH, WY, TX, NE, CA, MD, TX, OR IA, IL, MO, OR, NY, UT, PA, MA, GA, VA, WA, WI, and Internationally to :Aruba

AlaskaCaliforniaGeorgiaIowaIllinoisMassachusettsMarylandMissouriNebraskaNew HampshireNew YorkOregonPennsylvaniaTexasUtahVirginiaWashingtonWisconsinWyoming

Questions about this recall

Why was it recalled?

Software issue

Which lots are affected?

UDI?DI 00857050006014, Versions 4.8.2 SP6 - 4.8.3

Where was it sold?

US Distribution: AK, NH, WY, TX, NE, CA, MD, TX, OR IA, IL, MO, OR, NY, UT, PA, MA, GA, VA, WA, WI, and Internationally to :Aruba

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Imaging Equipment recalls

All 2,336